Lumos Diagnostics Partners with CG Life to Help Accelerate the U.S. Commercialization of FebriDx®
Bringing deep diagnostics and med-tech experience, CG Life will help expand awareness of FebriDx® through integrated marketing, demand generation, and account-based marketing programs focused on outpatient and urgent care providers across the United States. As commercial momentum grows, this investment strengthens the infrastructure to increase market awareness, generate qualified opportunities, and support broader adoption of FebriDx® across the U.S.
